Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Study Design in Statistics

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...

Study Designs in Epidemiology

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of Measurement Techniques for Photoreceptor Loss in Geographic Atrophy.

Translational vision science & technology·2026

Same author

Evaluating the inter-relationships among depression, anxiety and somatic symptoms in haemodialysis patients: a cross-sectional structural equation modelling study.

BMJ open·2026

Same author

The MLLT3 YEATS domain binds histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking transcription and RNA signaling to regulate hematopoiesis.

Cell reports·2026

Same author

Retinal vein occlusion.

Handbook of clinical neurology·2026

Same author

Impact of Aflibercept Dosing Frequency on Retinal Nonperfusion Progression Assessed by Ultra-Widefield Angiography After Endolaserless Vitrectomy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.

Journal of vitreoretinal diseases·2026

Same author

Broadband Access and Ophthalmologist Density in the United States: Cross-Sectional Questionnaire Study.

JMIR public health and surveillance·2026

Search research articles

Related Experiment Videos

SCORE Study report 3: study design and baseline characteristics.

Michael S Ip¹, Neal L Oden, Ingrid U Scott

¹University of Wisconsin Fundus Photograph Reading Center, Madison, WI, USA.

|July 22, 2009

Summary

This summary is machine-generated.

The Standard Care versus COrticosteroid for REtinal Vein Occlusion (SCORE) Study found significant baseline differences between central and branch retinal vein occlusions. These findings support evaluating central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) in separate clinical trials.

Related Experiment Videos

Area of Science:

Ophthalmology
Retinal Vascular Diseases
Clinical Trials

Background:

Retinal vein occlusions (RVO) are a significant cause of vision loss.
The Standard Care versus COrticosteroid for REtinal Vein Occlusion (SCORE) Study aimed to characterize participants and compare them to other RVO trials.
Understanding baseline characteristics is crucial for effective treatment strategies.

Purpose of the Study:

To describe baseline characteristics of participants in the SCORE Study.
To compare these characteristics between central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) cohorts.
To describe the SCORE Study design for future research.

Main Methods:

Two multicenter, Phase III, randomized clinical trials were conducted: one for CRVO and one for BRVO.
A total of 682 participants were enrolled (271 with CRVO, 411 with BRVO).
Demographic, ophthalmic, and medical history data were collected and compared.

Main Results:

CRVO participants had a mean visual acuity letter score of 51 (approx. 20/100) and a mean OCT-measured central subfield thickness of 595 microns.
BRVO participants had a mean visual acuity letter score of 57 (approx. 20/80) and a mean OCT-measured central subfield thickness of 491 microns.
Differences in visual acuity, retinal thickness, and leakage were observed between CRVO and BRVO groups.

Conclusions:

Observed baseline differences in visual acuity, retinal thickness, and leakage support separate evaluations for CRVO and BRVO.
This supports the design of distinct clinical trials for these two types of retinal vein occlusion.
Further research can now focus on tailored interventions for each specific occlusion type.